Nuo Therapeutics Company Profile (OTCMKTS:CMXI)

About Nuo Therapeutics

Nuo Therapeutics logoNuo Therapeutics, Inc., formerly Cytomedix, Inc., is a regenerative therapies company developing and marketing products within the United States and internationally through its strategic partners. The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company's commercial offerings are centered on its point of care platform technologies for the separation of blood and bone marrow to produce platelet based therapies or cell concentrates. It is promoting two distinct platelet rich plasma (PRP) technologies: the Aurix System for wound care, and the Angel concentrated Platelet Rich Plasma (cPRP) System for orthopedics and cardiovascular markets. The Company is focused on developing product candidates utilizing the Bright Cell technology platform, owned by its subsidiary, Aldagen, Inc.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: CMXI
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $
  • 200 Day Moving Average: $
  • Trailing P/E Ratio:
  • P/E Growth:
  • Market Cap: $
Additional Links:

Analyst Ratings

Consensus Ratings for Nuo Therapeutics (OTCMKTS:CMXI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Nuo Therapeutics (OTCMKTS:CMXI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Nuo Therapeutics (OTCMKTS:CMXI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/22/2014($0.04)($0.05)ViewN/AView Earnings Details
4/2/2014($0.04)($0.05)ViewN/AView Earnings Details
11/12/2013Q3($0.04)($0.05)ViewListenView Earnings Details
3/18/20134Q12($0.04)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Nuo Therapeutics (OTCMKTS:CMXI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Nuo Therapeutics (OTCMKTS:CMXI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Nuo Therapeutics (OTCMKTS:CMXI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/6/2014Dean TozerInsiderBuy33,300$0.36$11,988.00View SEC Filing  
9/12/2014Dean TozerInsiderBuy40,000$0.45$18,000.00View SEC Filing  
8/29/2014Dean TozerInsiderBuy40,000$0.35$14,000.00View SEC Filing  
8/26/2014Steven A ShallcrossCFOBuy27,500$0.38$10,450.00View SEC Filing  
8/22/2014Dean TozerInsiderBuy38,700$0.38$14,706.00View SEC Filing  
8/20/2014Dean TozerInsiderBuy48,000$0.39$18,720.00View SEC Filing  
8/20/2014Martin P RosendaleCEOBuy25,000$0.40$10,000.00View SEC Filing  
8/20/2014Steven A ShallcrossCFOBuy52,000$0.39$20,280.00View SEC Filing  
5/21/2013David Emerson JordenDirectorBuy80,000$0.50$40,000.00View SEC Filing  
4/19/2013David Emerson JordenDirectorBuy50,000$0.51$25,500.00View SEC Filing  
4/9/2013David Emerson JordenDirectorBuy75,000$0.51$38,250.00View SEC Filing  
4/4/2013Martin P RosendaleCEOBuy17,231$0.52$8,960.12View SEC Filing  
2/27/2013David Emerson JordenDirectorBuy25,000$0.52$13,000.00View SEC Filing  
2/22/2013Aldagen Holdings, LlcInsiderBuy281,819$0.55$155,000.45View SEC Filing  
2/22/2013David Emerson JordenDirectorBuy50,000$0.53$26,500.00View SEC Filing  
2/22/2013Martin P RosendaleCEOBuy20,000$0.53$10,600.00View SEC Filing  
2/19/2013Guercio Joseph DelDirectorBuy509,091$0.55$280,000.05View SEC Filing  
9/14/2012David Emerson JordenDirectorBuy25,000$0.89$22,250.00View SEC Filing  
9/11/2012David Emerson JordenDirectorBuy8,333$0.95$7,916.35View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headlines for Nuo Therapeutics (OTCMKTS:CMXI)
No headlines for this company have been tracked by MarketBeat.com

Social

What is Nuo Therapeutics' stock symbol?

Nuo Therapeutics trades on the OTCMKTS under the ticker symbol "CMXI."

How do I buy Nuo Therapeutics stock?

Shares of Nuo Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Nuo Therapeutics stock cost?

One share of Nuo Therapeutics stock can currently be purchased for approximately $0.34.

Nuo Therapeutics (OTCMKTS:CMXI) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Nuo Therapeutics (OTCMKTS:CMXI)

Earnings History Chart

Earnings by Quarter for Nuo Therapeutics (OTCMKTS:CMXI)

Dividend History Chart

Dividend Payments by Quarter for Nuo Therapeutics (OTCMKTS:CMXI)

Last Updated on 2/20/2017 by MarketBeat.com Staff